Keyphrases
Denmark
83%
Klebsiella Pneumoniae (K. pneumoniae)
67%
Escherichia Coli
61%
Bloodstream Infection
38%
Blood Culture
34%
Whole Genome Sequencing
26%
Copenhagen
25%
CTX-M-15
22%
Bacterial Isolates
21%
Third-generation Cephalosporins
20%
Cephalosporin Resistance
20%
Hypervirulent Klebsiella Pneumoniae
18%
Vancomycin-resistant Enterococci
18%
European Committee on Antimicrobial Susceptibility Testing (EUCAST)
18%
Sequence Type 131
18%
Sepsis
18%
Carbapenemase-producing Enterobacterales
18%
Haemophilus Influenzae
18%
Enterohemorrhagic Escherichia Coli
18%
Species Identification
18%
Extended-spectrum β-lactamase
17%
β-lactamase
17%
Clinical Setting
16%
ST131
15%
ST15
15%
Clonal Groups
14%
Pulsed-field Gel Electrophoresis
14%
Antimicrobial Susceptibility
14%
Increased Incidence
13%
Antimicrobial Resistance
13%
Phylogroup
13%
Sequence Type
13%
Point Prevalence Survey
13%
Enteroaggregative E. Coli
12%
Extended-spectrum-lactamase
12%
Gram-negative
12%
Whole Genome
12%
Clinical Microbiology Laboratory
11%
ST10
11%
Plasmid-mediated
11%
Pseudomonas Aeruginosa (P. aeruginosa)
11%
Vitek 2
11%
Resistant Bacteria
11%
Disc Diffusion
11%
BlaCTX-M
11%
Infection Control
10%
Urinary Tract Infection
10%
Enterobacterales
10%
Phylogenetic Groups
10%
Clinical Microbiology
10%
Immunology and Microbiology
Escherichia coli
100%
Klebsiella pneumoniae
75%
Prevalence
41%
Whole Genome Sequencing
33%
Plasmid
28%
Phylogeny
23%
Lineages
23%
Clinical Microbiology
23%
Infectious Agent
22%
Multilocus Sequence Typing
21%
Polymerase Chain Reaction
19%
Antimicrobial Resistance
19%
Enteroaggregative Escherichia Coli
18%
Carbapenemase Producing Enterobacteriaceae
18%
Vancomycin-Resistant Enterococcus
18%
Antibiotic Sensitivity
18%
Haemophilus influenzae
18%
Cladistics
17%
Staphylococcus Aureus
17%
Genome Sequencing
14%
Urinary Tract
14%
Minimum Inhibitory Concentration
13%
Candida Albicans
13%
Sequenced Genomes
13%
Abscess
12%
Biofilm
11%
Species Identification
11%
Disk Diffusion
10%
Single Nucleotide Polymorphism
10%
Enterobacterales
10%
Decision Making
9%
Enterobacteriaceae
9%
Escherichia
9%
Pharmacokinetics
9%
Mycoplasma pneumoniae
9%
Capnocytophaga
9%
Drug Dose Regimen
9%
Coinfection
9%
Meningitis
9%
Mental Capacity
9%
Pharmacodynamics
9%
Hemodialysis
9%
Candida Glabrata
9%
Colistin
9%
Serotype
9%
Polymerase Chain Reaction
9%
Pneumococcus
9%
Real Time Polymerase Chain Reaction
9%
Streptococcus Pneumoniae
8%
Extraintestinal Pathogenic Escherichia Coli
7%